Evidence map›Paper›PMID 32676436›Full record

ReviewTranslational andrology and urology2020

Can transrectal prostate ultrasound compete with multiparametric MRI in the detection of clinically significant prostate cancer?

Alistair D R Grey, Martin J Connor, Joseph Tam, Tillmann Loch

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational andrology and urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alistair D R GreyImperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Martin J ConnorImperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Joseph TamImperial Prostate, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Tillmann LochDepartment of Urology Diakonissenkrankenhaus, Flensburg, University Teaching Hospital of Christian-Albrechts-Universität Kiel, Flensburg, Germany.
Imperial College London · GBDiakonissenkrankenhaus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We consider the current and future role of transrectal ultrasound imaging in the diagnosis of prostate cancer, with a particular focus on the pre-biopsy localization and targeting role that multiparametric MRI (mpMRI) has come to occupy for some men in recent years. We draw a distinction between transrectal ultrasound (TRUS) used only as a means of distributing zonal biopsies with its employment as a means for identifying and targeting sonographically abnormal lesions. The role of AI in lesion identification and targeting will be reviewed. Comparisons of cost and availability, frequency of contraindications and diagnostic accuracy between these two imaging modalities will be drawn.

Indexed as

artificial neural network analysismultiparametric MRI (mpMRI)multiparametric ultrasoundProstate cancertransrectal ultrasound (TRUS)

Identifiers

PMID32676436
PMCPMC7354342
OpenAlexW3023662351

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.